Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-22

Clinical Trial Update: Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing THDB0206 to insulin lispro in adults with Type 2 diabetes mellitus has completed, with reported efficacy and safety results. The study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin lispro injection (insulin lispro)
  • THDB0206 (THDB0206)

Snippet

Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED